trending Market Intelligence /marketintelligence/en/news-insights/trending/5_LZodu_bKO2PCe_41tK7g2 content esgSubNav
In This List

Athyrium, Neuberger Berman close healthcare fund at $2.03B

Blog

Banking Essentials Newsletter 2021: December Edition

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Automating Credit Risk Surveillance Using Statistical Models

Blog

Post-webinar Q&A: Speed and Scalability – Automation in Credit Risk Modeling


Athyrium, Neuberger Berman close healthcare fund at $2.03B

Athyrium Capital Management LP and Neuberger Berman Group LLC have closed Athyrium Opportunities Fund III at approximately $2.03 billion.

The fund will be used to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The fund invests across the healthcare sector, including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.

NB Alternatives Advisers LLC acts as a sub-adviser to the fund.